Inhibition of human glutathione transferase P1-1 by novel benzazole derivatives;İnsan glutatyon transferaz P1-1'in benzozol türevleri tarafından inhibisyonu

Turkish Journal of Biochemistry

Volumn 37, Issue 4, 2012, Pages 431-436

  Musdal, Yaman ^a   Ertan Bolelli, Tugba ^b   Bolelli, Kayhan ^b   Yilmaz, Serap ^b   Ceyhan, Deniz ^a   Hegazy, Usama ^c,d   Mannervik, Bengt ^c,e   Aksoy, Yasemin ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c UPPSALA UNIVERSITY   (Sweden)

^d NATIONAL RESEARCH CENTRE   (Egypt)

^e STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Anti cancer drugs; Benzazole derivatives; Enzyme inhibition; GST P1 1

Indexed keywords

1 CHLORO 2, 4 DINITROBENZENE; 18 [N [2 (4 CHLORO BENZYL) BENZOOXAZOL 5 YL] 4 NITRO BENZENESULFONAMIDE]; BENZAZOLE DERIVATIVE; FUSED CARBON NITROGEN HETEROCYCLE; GLUTATHIONE TRANSFERASE P1; PHENETHYL ISOTHIOCYANATE; S HEXYLGLUTATHIONE; SEPHAROSE; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; CANCER CELL; ENZYMATIC ASSAY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PURIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IC 50; KINETICS; SPECTROPHOTOMETER;

EID: 84872540930     PISSN: None     EISSN: 1303829X     Source Type: Journal    
DOI: 10.5505/tjb.2012.30301     Document Type: Article

References (34)

1. Armstrong RN. Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem Res Toxicol 1997; 10:2-18.
2. Mannervik B, Board PG, Hayes JD, Listowsky I, Pearson WR. Nomenclature for mammalian soluble glutathione transferases. Methods Enzymol 2005; 401:1-8.
3. Josephy PD, Mannervik, B. Molecular toxicology (2nd ed.) 2006; pp. 333-364, Oxford University Press, New York; Oxford.
4. Blackburn AC, Woollatt E, Sutherland GR, Board PG. Characterization and chromosome location of the gene GSTZ1 encoding the human Zeta class glutathione transferase and maleylacetoacetate isomerase. Cytogenet Cell Genet 1998; 83:109-114.
5. Johansson AS, Mannervik B. Human glutathione transferase A3-3, a highly efficient catalyst of double-bond isomerization in the biosynthetic pathway of steroid hormones. J Biol Chem 2001; 276:33061-33065.
6. Hayes JD, Judah DJ, McLellan LI, Kerr LA, Peacock SD, et al. Ethoxyquin-induced resistance to aflatoxin B1 in the rat is associated with the expression of a novel alpha-class glutathione S-transferase subunit, Yc2, which possesses high catalytic activity for aflatoxin B1-8,9-epoxide. Biochem J 1991; 279(Pt 2):385-398.
7. Kamisaka K, Habig WH, Ketley JN, Arias M, Jakoby WB. Multiple forms of human glutathione S-transferase and their affinity for bilirubin. Eur J Biochem 1975; 60:153-161.
8. Tew KD, Bomber AM, Hoffman SJ. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. Cancer Res 1988; 48:3622-3625.
9. Arca P, Rico M, Brana AF, Villar CJ, Hardisson C, et al. Formation of an adduct between fosfomycin and glutathione: a new mechanism of antibiotic resistance in bacteria. Antimicrob Agents Chemother 1988; 32:1552-1556.
10. Fournier D, Bride JM, Poirie M, Berge JB, Plapp FW Jr. Insect glutathione S-transferases. Biochemical characteristics of the major forms from houseflies susceptible and resistant to insecticides. J Biol Chem 1992; 267:1840-1845.
11. Schisselbauer JC, Silber R, Papadopoulos E, Abrams K, LaCreta FP, et al. Characterization of glutathione S-transferase expression in lymphocytes from chronic lymphocytic leukemia patients. Cancer Res 1990; 50:3562-3568.
12. Tsuchida S, Sato K. Glutathione transferases and cancer. Crit Rev Biochem Mol Biol 1992; 27:337-384.
13. Sau A, Pellizzari Tregno F, Valentino F, Federici G, Caccuri AM. Glutathione transferases and development of new principles to overcome drug resistance. Arch Biochem Biophys 2010; 500:116-122.
14. Tew KD. TLK-286: a novel glutathione S-transferase-activated prodrug. Expert Opin Investig Drugs 2005; 14:1047-1054.
15. Bolelli K, Yalcin I, Ertan-Bolelli T, Ozgen S, Kaynak-Onurdag F, et al. Synthesis of novel 2-[4-(4-substitutedbenzamido/phenylacetamido)phenyl] benzothiazoles as antimicrobialagents. Med Chem Res 2011; 20:1-8.
16. Yildiz-Oren I, Yalcin I, Aki-Sener E, Ucarturk N. Synthesis and structure-activity relationships of new antimicrobial active multisubstituted benzazole derivatives. Eur J Med Chem 2004; 39:291-298.
17. Ertan T, Yildiz I, Tekiner-Gulbas B, Bolelli K, Temiz-Arpaci O, et al. Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents. Eur J Med Chem 2009; 44:501-510.
18. Akbay A, Oren I, Temiz-Arpaci O, Aki-Sener E, Yalcin I. Synthesis and HIV-1 reverse transcriptase inhibitor activity of some 2,5,6-substituted benzoxazole, benzimidazole, benzothiazole and oxazolo(4,5-b)pyridine derivatives. Arzneimittelforschung 2003; 53:266-271.
19. Ertan-Bolelli T. Synthesis, Structure Elucidation, Antimicrobial Activity and Molecular Modeling of Some New Sulfonamido Benzoxazole Derivatives. PhD Thesis 2012.
20. Temiz-Arpaci O, Ozdemir A, Yalcin I, Yildiz I, Aki-Sener, et al. Synthesis and antimicrobial activity of some 5-[2-(morpholin-4-yl)acetamido] and/or 5-[2-(4-substituted piperazin-1-yl) acetamido]-2-(p-substituted phenyl)benzoxazoles. Arch Pharm (Weinheim) 2005; 338:105-111.
21. Pinar A, Yurdakul, P, Yildiz I, Temiz-Arpaci O, Acan NL, et al. Some fused heterocyclic compounds as eukaryotic topoisomerase II inhibitors. Biochem Biophys Res Commun 2004; 317:670-674.
22. Ertan T, Yildiz I, Ozkan S, Temiz-Arpaci O, Kaynak F, et al. Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents. Bioorg Med Chem 2007; 15:2032-2044.
23. Kolm RH, Stenberg G, Widersten M, Mannervik B. High-level bacterial expression of human glutathione transferase P1-1 encoded by semisynthetic DNA. Protein Expr Purif 1995; 6:265-271.
24. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249:7130-7139.
25. Kolm RH, Danielson UH, Zhang Y, Talalay P, Mannervik B. Isothiocyanates as substrates for human glutathione transferases: structure-activity studies. Biochem J 1995; 311(Pt 2):453-459.
26. Mannervik B, Danielson UH. Glutathione transferases--structure and catalytic activity. CRC Crit Rev Biochem 1988; 23:283-337.
27. Yalcin S, Jensson H, Mannervik B. A set of inhibitors for discrimination between the basic isozymes of glutathione transferase in rat liver. Biochem Biophys Res Commun 1983; 114:829-834.
28. Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, et al. Regulation of JNK signaling by GSTp. EMBO J 1999; 18:1321-1334.
29. Dulhunty A, Gage P, Curtis S, Chelvanayagam G, Board P. The glutathione transferase structural family includes a nuclear chloride channel and a ryanodine receptor calcium release channel modulator. J Biol Chem 2001; 276:3319-3323.
30. Raffalli-Mathieu F, Persson D, Mannervik B. Differences between bovine and human steroid double-bond isomerase activities of Alpha-class glutathione transferases selectively expressed in steroidogenic tissues. Biochim Biophys Acta 2007; 1770:130-136.
31. Tew KD. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 1994; 54:4313-4320.
32. Hayeshi R, Chinyanga F, Chengedza S, Mukanganyama S. Inhibition of human glutathione transferases by multidrug resistance chemomodulators in vitro. J Enzyme Inhib Med Chem 2006; 21:581-587.
33. Carrassa L, Chila R, Lupi M, Ricci F, Celenza C, et al. Combined inhibition of Chk1 and Wee1: in vitro synergistic effect translates to tumor growth inhibition in vivo. Cell Cycle 2012; 11:2507-2517.
34. Davies KD, Cable PL, Garrus JE, Sullivan FX, von Carlowitz I, et al. Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation. Cancer Biol Ther 2011; 12:788-796.